We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00510718
Recruitment Status : Active, not recruiting
First Posted : August 2, 2007
Last Update Posted : March 8, 2018
Astellas Pharma Inc
Medivation, Inc.
Information provided by (Responsible Party):